| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/27/2023 | Black Diamond Therapeutics, Inc. | BDTX | Sale | Common Stock | 25k | $6.70 | $167.5k | | 06/27/2023 |
| 02/15/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 300k | $3.79 | $1.1M | | 02/15/2022 |
| 02/17/2021 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 225k | $28.69 | $6.5M | | 02/17/2021 |
| 01/04/2021 | Black Diamond Therapeutics, Inc. | BDTX | Exercise | Stock Option (Right to Buy) | 3k | $6.42 | $19.3k | | 01/04/2021 |
| 01/04/2021 | Black Diamond Therapeutics, Inc. | BDTX | Sale | Common Stock | 2k | $31.80 | $64.1k | | 01/04/2021 |
| 01/04/2021 | Black Diamond Therapeutics, Inc. | BDTX | Sale | Common Stock | 10k | $30.99 | $309.4k | | 01/04/2021 |
| 12/15/2020 | Black Diamond Therapeutics, Inc. | BDTX | Exercise | Stock Option (Right to Buy) | 2.5k | $6.42 | $16k | | 12/15/2020 |
| 12/01/2020 | Black Diamond Therapeutics, Inc. | BDTX | Sale | Common Stock | 10.9k | $32.64 | $356.6k | | 12/01/2020 |
| 12/01/2020 | Black Diamond Therapeutics, Inc. | BDTX | Sale | Common Stock | 1.1k | $33.45 | $36k | | 12/01/2020 |
| 12/01/2020 | Black Diamond Therapeutics, Inc. | BDTX | Exercise | Stock Option (Right to Buy) | 3k | $6.42 | $19.3k | | 12/01/2020 |
| 11/02/2020 | Black Diamond Therapeutics, Inc. | BDTX | Exercise | Stock Option (Right to Buy) | 3k | $6.42 | $19.3k | | 11/02/2020 |
| 11/02/2020 | Black Diamond Therapeutics, Inc. | BDTX | Sale | Common Stock | 83 | $31.88 | $2.6k | | 11/02/2020 |
| 11/02/2020 | Black Diamond Therapeutics, Inc. | BDTX | Sale | Common Stock | 11.9k | $31.13 | $371k | | 11/02/2020 |
| 10/01/2020 | Black Diamond Therapeutics, Inc. | BDTX | Sale | Common Stock | 12k | $30.33 | $364k | | 10/01/2020 |
| 10/01/2020 | Black Diamond Therapeutics, Inc. | BDTX | Exercise | Stock Option (Right to Buy) | 3k | $6.42 | $19.3k | | 10/01/2020 |
| 02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Series A Preferred Stock | 69.6k | $0.00 | $0 | See Footnote | 02/03/2020 |
| 02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Series A Preferred Stock | 732.6k | $0.00 | $0 | | 02/03/2020 |
| 02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Series B Preferred Stock | 13.1k | $0.00 | $0 | | 02/03/2020 |
| 02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Common Stock | 4.4k | $0.00 | $0 | | 02/03/2020 |
| 02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Common Stock | 23.1k | $0.00 | $0 | See footnote | 02/03/2020 |
| 02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Common Stock | 242.9k | $0.00 | $0 | | 02/03/2020 |
| 01/29/2020 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 278.5k | $19.00 | $5.3M | | 01/29/2020 |
| 06/07/2010 | OSI PHARMACEUTICALS INC | OSIP | Other | Common Stock | 8 | $57.50 | $460 | | 06/07/2010 |
| 05/01/2010 | OSI PHARMACEUTICALS INC | OSIP | Payment of Exercise | Common Stock | 906 | $58.67 | $53.2k | | 05/01/2010 |